Cargando…
Advance in Research on Mycobacterium tuberculosis FabG4 and Its Inhibitor
Increasing evidence from recent reports of drug-resistant mycobacterial strains poses a challenge worldwide. Drug-resistant strains often undergo mutations, adopt alternative pathways, and express drug efflux pumps to reduce or eliminate drug doses. Besides these intrinsic resistance mechanisms, bac...
Autor principal: | Dutta, Debajyoti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008564/ https://www.ncbi.nlm.nih.gov/pubmed/29946302 http://dx.doi.org/10.3389/fmicb.2018.01184 |
Ejemplares similares
-
Crystallization and preliminary X-ray diffraction analysis of the high molecular weight ketoacyl reductase FabG4 complexed with NADH. Corrigendum
por: Dutta, Debajyoti, et al.
Publicado: (2012) -
The essential mycobacterial genes, fabG1 and fabG4, encode 3-oxoacyl-thioester reductases that are functional in yeast mitochondrial fatty acid synthase type 2
por: Gurvitz, Aner
Publicado: (2009) -
Tachyplesin Causes Membrane Instability That Kills Multidrug-Resistant Bacteria by Inhibiting the 3-Ketoacyl Carrier Protein Reductase FabG
por: Liu, Cunbao, et al.
Publicado: (2018) -
Structural Characterisation of FabG from Yersinia pestis, a Key Component of Bacterial Fatty Acid Synthesis
por: Nanson, Jeffrey D., et al.
Publicado: (2015) -
Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification
por: Faïon, Léo, et al.
Publicado: (2023)